Forlax

Forlax Special Precautions

macrogol 3350 and 4000

Manufacturer:

Ipsen CHC

Distributor:

Zuellig Pharma

Marketer:

EP Plus Group
Full Prescribing Info
Special Precautions
Special Warning: The treatment of constipation with any medicinal product is only an adjuvant to a healthy lifestyle and diet, for example: increase intake of liquids and dietary vegetable fiber, advice on appropriate physical activity and rehabilitation of the bowel reflex.
An organic disorder should have been ruled out before initiation of treatment.
This medicine contains macrogol (polyethylene glycol).
Hypersensitivity (anaphylactic shock, angioedema, urticaria, rash, pruritus, erythema) to drugs containing macrogol (polyethylene glycol) have been reported, see Adverse Reactions.
This medicine contains sulphur dioxide, which may rarely cause severe hypersensitivity reactions and bronchospasm.
This medicine contains sorbitol. Patients with hereditary problems of fructose intolerance should not take this medicinal product.
In case of diarrhoea, caution should be exercised in patients prone for disturbances of water-electrolyte balance (e.g. elderly, patients with impaired hepatic or renal function or patients taken diuretics) and electrolyte control considered.
Cases of aspiration have been reported when extensive volumes of polyethylene glycol and electrolytes were administered with nasogastric tube. Neurologically impaired children who have oromotor dysfunction are particularly at risk of aspiration.
4 g: Data on a limited number of patients on efficacy in children under the age of 2 years have been obtained.
After a 3-month treatment course, a complete clinical supervision of constipation should be performed.
Precaution for use: The medicinal product does not contain a significant quantity of sugar or polyol and can be prescribed to diabetic patients or patients on a galactose-free diet.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in